These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24560645)

  • 21. Delivery of biotherapeutics by inhalation aerosol.
    Niven RW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers.
    Bhalla RK; Watson G; Taylor W; Jones AS; Roland NJ
    J Asthma; 2008 Nov; 45(9):814-9. PubMed ID: 18972301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer.
    Bisgaard H
    Am J Respir Crit Care Med; 1998 Feb; 157(2):518-21. PubMed ID: 9476867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence of inhaled drugs.
    Derom E; Pauwels R
    Eur Respir J; 1995 Oct; 8(10):1634-6. PubMed ID: 8586113
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].
    Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C
    Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Good practice for aerosol therapy by nebulisation].
    Dautzenberg B; Becquemin MH; Chaumuzeau JP; Diot P;
    Rev Mal Respir; 2007 Jun; 24(6):751-7. PubMed ID: 17632434
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization].
    Boe J; Dennis JH; O'Driscoll BR; Bauer TT; Carone M; Dautzenberg B; Diot P; Heslop K; Lannefors L;
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):1033-8. PubMed ID: 15622355
    [No Abstract]   [Full Text] [Related]  

  • 31. Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Shen M; Lostritto RT; Poochikian GK
    J Biopharm Stat; 2008; 18(5):976-84. PubMed ID: 18781529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN; Bjermer L; Lavorini F; Ninane V; Molimard M; Haughney J
    Respir Med; 2014 May; 108(5):694-700. PubMed ID: 24636812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metered-dose inhalers, dry powder inhalers, and transitions.
    Fink JB
    Respir Care; 2000 Jun; 45(6):623-35. PubMed ID: 10894455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization].
    Becquemin MH; Chaumuzeau JP
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):889-90. PubMed ID: 15622332
    [No Abstract]   [Full Text] [Related]  

  • 36. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unknown risks of pharmacy-compounded drugs.
    Sasich LD; Sukkari SR
    J Am Osteopath Assoc; 2008 Feb; 108(2):86. PubMed ID: 18303067
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
    Westerman EM; De Boer AH; Le Brun PP; Touw DJ; Roldaan AC; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2007 Jul; 6(4):284-92. PubMed ID: 17185047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence logger for a dry powder inhaler: a new device for medical adherence research.
    Bogen D; Apter AJ
    J Allergy Clin Immunol; 2004 Oct; 114(4):863-8. PubMed ID: 15480328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.